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ABSTRACT
The replication of the genomic RNA of the hepatitis
C virus (HCV) of positive polarity involves the syn-
thesis of a replication intermediate of negative
polarity by the viral RNA-dependent RNA poly-
merase (NS5B). In vitro and likely in vivo, the NS5B
initiates RNA synthesis without primers. This de
novo mechanism needs specific interactions
between the polymerase and viral RNA elements.
Cis-acting elements involved in the initiation of (–)
RNA synthesis have been identified in the
30 non-coding region and in the NS5B coding
region of the HCV RNA. However, the detailed con-
tribution of sequences and/or structures of (–) RNA
involved in the initiation of (+) RNA synthesis has
been less studied. In this report, we identified
an RNA element localized between nucleotides 177
and 222 from the 30-end of the (–) RNA that is nec-
essary for efficient initiation of RNA synthesis by the
recombinant NS5B. By site-directed mutagenesis
experiments, we demonstrate that the structure
rather than the primary sequence of this domain is
important for RNA synthesis. We also demonstrate
that the intact structure of this RNA element is also
needed for efficient RNA synthesis when the viral
NS5B functions in association with other viral and
cellular proteins in cultured hepatic cells.
INTRODUCTION
Hepatitis virus C (HCV) is a virus of the Flaviviridae
family that induces severe liver diseases in human (1).
The viral genome is a single-stranded RNA of positive
polarity containing a single open reading frame (ORF)
ﬂanked by the two untranslated regions (UTRs), the
50UTR and 30UTR (2). Translation of the ORF is initiated
through an internal ribosome entry site (IRES) present in
the 50UTR (3). The polyprotein produced after complete
ORF translation is cleaved by cellular and viral proteases
to generate the structural proteins (capsid, C and enve-
lopes, E1 and E2) and seven non-structural proteins (p7,
NS2, NS3, NS4A, NS4B, NS5A and NS5B). In hepatoma
cells, the nonstructural proteins assemble with cellular
proteins (4) in a cell compartment derived from the
endoplasmic reticulum, termed ‘membranous web’ (5), to
form the replication complex (RC) responsible for viral
RNA synthesis (6). The catalytic subunit of the RC is
the NS5B protein that harbors an RNA-dependent
RNA polymerase activity in vitro (7,8) but it has been
shown that the NS3 to NS5B proteins are necessary for
viral RNA synthesis in hepatoma cells (9). The 30UTR is
composed of a short variable region, a polypyrimidine
tract (poly U-UC) of variable length and a highly
conserved 98-nt segment (30X). The two latter domains
are essential for viral infectivity in vivo (10) and RNA
replication of HCV replicons (11,12).
During HCV RNA replication, the viral RC synthesizes
a minus-strand RNA that serves as a template for the
synthesis of new plus-strand RNA molecules. In vitro
and most probably in vivo, the NS5B polymerase initiates
RNA synthesis by a de novo mechanism at the 30-end of
the plus and minus strand RNA (13–16). Initiation of
RNA synthesis involves interactions between the protein
components of the replication complex, in particular with
the viral polymerase (NS5B), and structures and/or
sequences of the viral RNA templates. The involvement
of the three stem–loops of the 30X has been extensively
studied both in cell culture using the replicon system and
in vitro (11,12,17). More recently, it has been reported that
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coding region form long-range RNA–RNA interactions
necessary for HCV replication (18–20). The secondary
structure of the 30-end of the minus-strand RNA comple-
mentary of the 50UTR has been also established (21,22)
but the detailed contribution of sequences and/or struc-
tures in the RNA synthesis has been less studied. The
222nt at the 30-end fold in 5 stable stem–loops that are
identical in the two models. Conversely, the structure of
upstream sequences is less stably organized and depends
on the length of the analyzed RNA (23). We have
previously shown that the 341nt of the 30-end of the
minus strand RNA are eﬃciently replicated by puriﬁed
HCV NS5B in vitro and that initiation occurs by a
de novo mechanism on the 30 cytosine (24). This high
level of RNA synthesis relies on sequences and/or struc-
tures present near the 30-end but also on upstream
domains (25). Comparable observations were made in a
cellular system using a HCV replicon for which it was
shown that the 125nt at the 30-end of the minus strand
RNA were suﬃcient for RNA synthesis, but that the
341nt were needed to obtain an optimal level of replica-
tion of the replicon (26,27).
In the present work, we investigated in detail the role of
the sequence and structure of the SL-E1 stem–loop
formed by nucleotides 177–222 from the 30-end of the
HCV minus strand RNA, ﬁrst in vitro by using model
RNAs and a recombinant NS5B protein and then in
Huh7 cells harboring the viral RC.
MATERIALS AND METHODS
RNA templates
The 341-nt-long RNA corresponding to the 30-end of the
minus-strand RNA was synthesized by in vitro transcrip-
tion of DNA template obtained by polymerase chain
reaction (PCR) ampliﬁcation from the pGEM-T 439 con-
taining the 439nt of the 50-end of pCV-H77 (28) kindly
provided by J. Bukh (NIH, Bethesda, Maryland, USA).
The PCR primers 50S7 and 50341T7-2 were designed
to introduce a T7 RNA polymerase promoter in the
correct orientation (Table S1). PCR was performed with
the AmpliTaq gold DNA polymerase kit (Perkin
Elmer). In vitro transcripts were synthesized using the
MEGAscript kit (Ambion). DNA templates were
digested with DNase I for 15min. After phenol/chloro-
form extraction, the RNAs were precipitated with
isopropanol and 0.5M ammonium acetate. The purity
and the integrity of synthesized RNAs were determined
by analysis on a 6% polyacrylamide gel containing 7M
urea in TBE buﬀer (90mM Tris–borate pH 8.0, 1mM
EDTA). All RNA mutants were obtained by modiﬁcation
of the 50 UTR sequence contained in the pGEM-T 439
using the QuikChange Site-Directed Mutagenesis Kit
(Stratagen) and oligonucleotides described in Table S2.
The sequence of mutated fragments was veriﬁed by
DNA sequencing using the ABI Prism Big Dye terminator
sequencing kit.
RdRp assay
The recombinant HCV NS5B-21 of HCV J4 (genotype
1b) expressed in Escherichia coli and puriﬁed as previously
described (25) was used in all experiments. The assay was
performed in a total volume of 20ml containing 20mM
Tris–HCl pH 7.5, 1mM DTT, 5mM MgCl2,4 0 m M
NaCl, 17U RNasin (Promega), the 3 rNTP (ATP, CTP
and GTP) 0.5mM each, 86nM of RNA template, 200nM
of puriﬁed NS5B and either 10mCi [a-
32P]UTP
(3000Ci mmol
–1, Amersham Pharmacia Biotech) and
2mM UTP or 2mCi [
3H]UTP (46Ci mmol
–1). The
reaction mixture was incubated for 2h at 25 C and
stopped by addition of 10% trichloracetic acid (TCA).
The radioactivity incorporated into neo- synthesized
RNA was then determined by scintillation counting.
To quantify and analyze the
32P-labeled RNA, the
synthesis was stopped by adding 6.25mM EDTA,
10mM Tris–HCl pH 7.5 and 0.125% SDS. An aliquot
of the reaction products was precipitated by 10% TCA
and the radioactivity incorporated in neo-synthesized
RNA was determined as above. The remainder of the
products was puriﬁed by phenol/chloroform extraction
(1/1 vol/vol) and precipitated by 1vol of isopropanol in
the presence of 0.5M ammonium acetate. RNAs were
dissolved in 95% formamide, 0.5mM EDTA, 0.025%
SDS, 0.025% bromophenol blue, 0.025% xylene cyanol
and then heated for 2min at 94 C. The same amount
(50000c.p.m.) of each sample was loaded onto a 6%
polyacrylamide denaturing gel containing 7M urea in
TBE buﬀer. After electrophoresis, the labeled RNA
products were visualized by electronic autoradiography
with a Pharos apparatus (Biorad).
For single-round replication assay, HCV RdRp and
RNA were pre-incubated for 30min at 25 C in the same
reaction mixture as above but without ATP and UTP.
Heparin (MW 4000–6000Da, 200mg/ml), then ATP and
[
32P]UTP were successively added. The reaction mixture
was further incubated at 25 C for 0, 5, 10, 20 or 60min.
The
32P RNA products were quantiﬁed after TCA precip-
itation or analyzed on polyacrylamide gels as described in
the above paragraph.
Gel-based initiation assay
The assay was carried out in 20ml of 20mM Tris pH 7.4,
50mM NaCl, 5mM MgCl2, 1mM DTT, 0.4U/ml RNasin,
1mM RNA template, 1mM NS5B. The initiation phase
was analyzed by adding 0.5mM GTP and 10mM CTP
with 4mCi [a-
32P] CTP (3000Cimmol
–1) only. At diﬀerent
time points, 4ml were collected, the reaction was quenched
by adding 1ml of 100mM SDS and diluted in 8mlo f
formamide/dyes loading buﬀer. After denaturation at
70 C for 5min, samples were loaded onto a 20%
polyacrylamide gel in TBE buﬀer containing 7M urea.
The migration was performed at 30W for 3h and the
gel was submitted to electronic autoradiography. The
pppGpC molecular weight marker was synthesized as
previously described (29).
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RNAs were labeled by in vitro transcription using the
MEGAscript kit (Ambion) and 15mCi [a-
32P]UTP
(Amersham Pharmacia Biotech). The amount of radioac-
tivity incorporated into the nucleic acids was measured by
precipitating 2-ml aliquots with 10% TCA and counting in
a Wallac scintillation counter. RNAs were precipitated
with isopropanol and dissolved in water.
Labeled RNA was thermally denatured for 2min at
94 C, and then quickly cooled on ice for 5min. RNA
at a concentration of 13nM (10000c.p.m.) was renatured
at 25 C for 10min in 9ml RdRp reaction mixture (without
NTP) before adding 200–1600nM of enzyme (in a 1-ml
volume). The incubation was continued for 20min at
25 C. Two microliters of electrophoresis loading buﬀer
(10mM Tris pH 8.0, 1mM EDTA, 0.1% bromophenol
blue, 0.1% xylene cyanol, 30% glycerol) were added to
the samples before loading onto a non-denaturing 4%
polyacrylamide gel (acrylamide:bis acrylamide 59/1). The
samples were run at 200V at room temperature. The gel
was autoradiographied and scanned using the NIH Image
J program. The percentage of bound RNA was plotted
against the concentration of NS5B. The apparent Kd
(kdapp) is deﬁned as the concentration of the NS5B
resulting in 50 % shifting of [
32P] RNA.
32P RNA labeling at the 50- and 30-ends
For 50-end
32P labeling, in vitro transcribed RNAs were
dephosphorylated with calf intestine alkaline phosphatase
(Roche) following the manufacturer’s instructions. The
dephosphorylated RNA was labeled with [g-
32P] ATP
and T4 polynucleotide kinase (Promega) according to
standard procedure and puriﬁed with GeBAﬂex-tube
dialysis and extraction kit (Gene Bio-Application) after
electrophoresis on 6% polyacrylamide denaturing gel.
For 30-end
32P labeling, RNAs with a deletion of the 30C
were synthesized in vitro as described above and labeled
with [
32P]pCp (Amersham Pharmacia Biotech) and T4
RNA ligase following the standard procedure. The
labeled RNAs were puriﬁed as described above.
Primer extension and sequence with labeled primers
Control or modiﬁed RNAs (0.2mg) was mixed with
32P
labeled probe (5 10
5c.p.m.) in a 9ml ﬁnal volume,
denatured for 1min at 90 C, quickly cooled on ice and
incubated for 5min at room temperature. Reverse tran-
scription was performed by using SuperScript II following
the manufacturer instructions (Invitrogen) at 45 C
for 30min in a ﬁnal volume of 15ml. The reaction
was stopped by adding 20ml of stop solution (50mM
Tris–HCl pH 8.5, 0.1% SDS). The RNA was hydrolyzed
by treatment with 0.4M KOH for 3min at 90 C and 3h at
37 C. After neutralization, DNA was precipitated by
ethanol and 0.3M sodium acetate. The sequence
reaction was performed by using the Thermo Sequenase
Cycle sequencing Kit (USB Corporation). Labeled
products were analyzed on an 8% polyacrylamide
denaturing gel containing 7M urea in TBE buﬀer.
Nuclease mapping
32P-labeled RNAs (100000c.p.m.) in 4mlH 2O were
denatured by heating at 94 C for 1min and cooled on
ice for 1min and then at room temperature for 5min.
RNA were then renatured for 10min at room temperature
after addition of 2ml of 5X buﬀer (ﬁnal concentration:
20mM Tris–acetate pH 7.6, 5mM magnesium acetate
and 100mM sodium acetate) and 1ml tRNA (1mg/ml).
The reaction volume was adjusted to 10ml after addition
of 1ml of RNase T1 (0.25U/ml, Ambion) and samples
incubated at 37 C for 5min. After precipitation by
adding 10ml 0.3M ammonium acetate and 90ml ethanol,
the reaction products were collected by centrifugation and
dissolved in 7ml of gel loading buﬀer II (Ambion). For
each RNA sample, a control reaction was performed in
the same reaction buﬀer without RNase T1. RNase T1
digestion in denaturing condition and alkaline hydrolysis
of
32P-labeled RNAs (100000c.p.m.) were performed with
buﬀers and conditions described with RNase T1
(Ambion). The diﬀerent reaction products were heated
at 94 C for 2min and loaded on an 8% polyacrylamide
8M urea denaturing gel, 3ml were run for 1.5h and 3ml
were run for 2.5h at 75W. After migration, the gels were
dried and autoradiographied with a hyperﬁlm MP
(Amersham Pharmacia Biotech).
Chemical probing
Before reaction with Pb
2+ ions, DEPC or DMS, RNAs
were denatured at 94 C for 1min and then renatured for
10min at room temperature after addition of 5  buﬀer.
Lead cleavage.
32P-labeled RNA (100000c.p.m.) and
yeast RNA (1mg) in 20mM HEPES-NaOH pH 7.5,
5mM magnesium acetate, 50mM potassium acetate and
25mM lead acetate were incubated for 1min at 20 Ci na
10ml ﬁnal volume. The reaction was stopped by adding
30ml of gel loading buﬀer (95% formamide, 7mM EDTA,
0.025% SDS and 0.025% bromophenol blue and xylene
cyanol). A control reaction in the same reaction buﬀer
without lead addition was performed with each RNA
preparation.
DEPC modiﬁcation. The reaction in native conditions was
performed in a 20ml reaction mixture containing
32P-labeled RNA (100000c.p.m.) and yeast RNA (2mg)
in 25mM Tris–HCl pH 7.5, 5mM MgCl2 and 25mM
KCl. One microliter of DEPC was then added. After incu-
bation for 20min at room temperature, RNA was
precipitated by sodium acetate and ethanol. DEPC mod-
iﬁcation in denaturing conditions was performed in
25mM HEPES-NaOH pH 7.5, EDTA 1mM and DEPC
(same concentration as above) for 1min at 70 Ct o9 0  C
as indicated in the ﬁgure legend. After ethanol precipita-
tion, RNAs were dissolved in 10ml 1M aniline pH 4.6 and
incubated for 10min at 60 C. After precipitation with
ethanol, the RNAs were dissolved in gel loading buﬀer
and analyzed on polyacrylamide gel as above. When
DEPC modiﬁcations were monitored by primer extension,
1mg of unlabeled RNA and 1mg of yeast RNA were
incubated in a 20-ml reaction mixture containing 25mM
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microliter of DEPC was then added. After incubation
for 20min at room temperature, RNAs was precipitated
by sodium acetate and ethanol and used in primer exten-
sion experiments. A control reaction in the same reaction
buﬀer without DEPC addition was performed with each
RNA preparation.
DMS modiﬁcation. RNA (1mg) and yeast RNA (1mg)
were incubated for 10min at room temperature in a
20ml solution containing 25mM Tris–HCl pH 7.5, 5mM
MgCl2 and 25mM KCl and 1ml of DMS (1/8 dilution in
ethanol). The reaction products were precipitated by
ethanol as above and used in primer extension experi-
ments. A control reaction in the same reaction buﬀer
without DMS addition was performed with each RNA
preparation.
Cell culture and transfection
All cell lines were cultured in Dulbecco’s modiﬁed Eagle
medium supplemented with 10% heat-inactivated fetal
calf serum and gentamycin (50mg/ml) at 37 Ci na5 %
CO2 H2O saturated atmosphere. The Huh7-QR and
Huh7/Rep5.1 cell lines, HCV RC-negative and HCV
RC-positive respectively, have been previously described
(30,31). For transfection experiments, 24h before
transfection, 10
5 of the appropriate cells were seeded in
24-well plates. RNA transfection was performed by using
DMRIE-C (Invitrogen) according to the manufacturer’s
protocol.
Translation and luciferase assay
The pIRF plasmid (32) was used to evaluate the IRES
activity of wild type (WT) and mutated HCV 50UTR.
The original pIRF plasmid was modiﬁed by inserting the
HCV 30UTR downstream from the Renilla gene as
described by Dumas et al. (33). The ﬁrst 368bp of the
HCV H77 DNA were PCR-ampliﬁed with primers
Bam_5UTR and Pst1-439 (Supplementary Table S1)
that introduced a BamH1 and a Pst1 site at the 50- and
at the 30-ends, respectively. After digestion with the restric-
tion enzymes, the DNA fragments were introduced
upstream of the Renilla luciferase into the pIRF plasmid
cleaved by the same enzymes. After DNA sequencing to
verify the sequence, the pIRF plasmids were linearized
with Xho1 and used as templates for in vitro RNA tran-
scription with the Amplicap T7 Kit (Epicentre
Biotechnology). The RNA were transfected into
Huh7-QR cells as described above and the enzymatic
activities of the Fireﬂy (Fluc) and the Renilla (Rluc)
luciferases were measured by using the Dual-Luciferase
Reporter assay system (Promega) 24h after transfection.
Minigenome replication assay
The minigenome construct pGEM-T/5UTR-H2AE-
3UTR has been previously described (30). The basic con-
struct contains the 50UTR, the ﬁrst 27nt of the core
coding sequence and the 30UTR of HCV Con1. These
three domains were ﬁrst replaced by those of the HCV
H77. Sequences of the H77-HCV 30UTR were
PCR-ampliﬁed with primers Xba_3UTR_H77 and
Sph1_3UTR_stop (Table S1) and Taq fusion polymerase
(Finnzyme) to introduce Xba1 and Sph1 restriction sites
at the 50- and 30-ends, respectively. After cleavage by
the restriction enzymes, the fragment was inserted at the
same sites in the pGEM-T/5UTR-H2AE-3UTR to give
the pGEM-T/5UTR-H2AE-3UTRH77. Sequences of the
H77-HCV 50UTR were ampliﬁed from the pGEM-T 439
with the SpeI_5UTR_H77_st and Corefus_BamH1_Stop
(Supplementary Table S1) to insert the Spe1 and BamH1
site at the 50- and 30-ends, respectively. After cleavage by
the restriction enzymes, the fragment was introduced
between the same restriction sites of the pGEM-T/
5UTR-H2AE-3UTRH77 to give the pGEM-T/5UTRH77-
H2AE-3UTRH77. Mutated 50UTR were introduced in
the same way instead of the WT 50UTR. The RNA tran-
scripts from wild type and mutated 5UTRH77-
H2AE-3UTRH77 were obtained as previously described
(30), except that an acidic phenol treatment was added
after incubation with DNase I to eliminate all DNA tem-
plates. The RNA minigenomes were transfected into
Huh7/Rep5.1 cells (four wells of 24-well plates for each
construct) as described above. Sixteen hours after
transfection, the percentage of transfected cells from two
wells was evaluated by ﬂow cytometry as previously
described (30). Forty-eight hours after transfection, the
two remaining wells were trypsinized, transferred to
Petri dishes (100mm diameter) and maintained for 3
weeks in DMEM medium supplemented with 500mg/ml
G418and 50mg/ml hygromycin. Colonies were stained
with Coomassie brilliant blue (2.5g/liter in 45%
methanol and 10% acetic acid).
Northern blot analysis
Total cellular RNAs were isolated using the TRIzol
Reagent (Invitrogen) following the manufacturer’s
instructions. RNA (10mg) obtained from Huh7/Rep5.1
cells 4h after transfection were denatured in MOPS
buﬀer (20mM MOPS pH 7, 5mM sodium acetate,
0.5mM EDTA), 50% formamide, 2.2M formaldehyde
for 15min at 55 C. After electrophoresis in a 1%
agarose gel in MOPS buﬀer 2.0M formaldehyde, RNAs
were transferred by capillarity in 20 SSC (3M NaCl, 0.3M
sodium citrate) onto nylon membrane (Hybond N,
Amersham Pharmacia Biotech) and UV cross-linked.
Membranes were hybridized with
32P-labeled EGFP or
GAPDH probes as previously described (33). The
32P-EGFP probe was synthesized with Prime-It II
Random Primer labeling Kit (Stratagene) using a 520-bp
DNA template obtained by PCR with EGFP-S3 and
EGFP-AS3 primers (Supplementary Table S1). The
32P-GAPDH probe was synthesized following the same
procedure from a 232-bp DNA template obtained by
PCR with GAPDH (+) and GAPDH (–) primers
(Supplementary Table S1). After hybridization, the
nylon membrane was washed as previously described
(33) and labeled bands visualized using a Pharos appara-
tus (Biorad).
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Mutations in the SL-E1 domain decreased in vitro
RNA synthesis
Earlier studies showed that sequences and/or structures
in the 125nt at the 30-end of the HCV minus strand
RNA are important for RNA synthesis in vitro
(24,25,34) and in Huh7 cells (26,27). However, data
from the same groups and of Van Leeuwen and col-
leagues (35) indicated that upstream sequences were nec-
essary to obtain a high level of RNA synthesis. To
identify these sequences more precisely, we decided to
investigate the role of the SL-E1 stem–loop formed by
nucleotides 177–222 from the 30-end of this RNA for two
reasons. First, we have previously shown that hybridiza-
tion of antisense oligonucleotides to the region comprised
between nucleotides 216 and 255 from the 30-end strongly
inhibits in vitro RNA synthesis (36). Second, the 30
border of the apical loop of the hairpin formed by
nucleotides 177 and 222 (named SL-E1 or IIIb0) bears
a 6-nt sequence (GAAAGG) homologous to the SL II
stem–loop of the 30X present in the plus strand RNA
(21,22). Synthesis was performed by using an RNA
template corresponding to the 341nt of the 30-end from
the HCV minus strand RNA and a recombinant NS5B
deprived of the 21C-terminal amino acids. Nucleotide
changes were introduced in the apical loop and in the
upper part of the stem to modify the sequence homolo-
gous to the loop of SLII of the 30UTR, and at the
bottom of the stem to destabilize the sequence where
inhibitory antisense oligonucleotides hybridized (Figure
1A). The mutants were designed so that the base
changes did not alter the secondary structures of the
other domains of the 341nt RNA as determined with
the RNADraw software.
As shown with the mutants G192A-G193A (2GA),
A194U-A195U-A196U (3AU) and G197C (GC),
changes of 1–3 residues in the upper part of the stem–
loop did not decrease RNA synthesis (Figure 1B).
A slight increase in RNA synthesis was even observed
with 2GA and 3AU mutants. Even when all six residues
homologous to SLII (SLE1AL mutant) were changed,
RNA synthesis was unaﬀected as compared to wild-type
(WT) RNA. Conversely, mutations G218A-G219A
(2A mutant) and G218A-G219A plus G177A-G178A
(4A mutant) that were predicted to disrupt the lower
part of the helix reduced RNA synthesis by 53% and
48%, respectively. Altogether, these data suggested
that the structure rather than the sequence of SL-E1
stem–loop contributed to eﬃcient replication of this
template RNA.
To test this hypothesis, we constructed another RNA
mutant for which the 2C residues at positions 180 and 181
were changed to U so as to restore base-pairing in the 2A
mutant (2AU mutant). As shown in Figure 1B, these mod-
iﬁcations completely restored the level of RNA synthesis,
strongly suggesting that the native structure of this RNA
domain is important for eﬃcient RNA synthesis from the
30end of the HCV minus strand RNA by the NS5B
polymerase in vitro.
RNA structure probing of wild-type and mutant RNAs
To conﬁrm that nucleotide modiﬁcations introduced into
2A and 4A mutants induced a structural change of SL-E1
stem, we compared their folding with that of the wild-type
341nt RNA. To do this, RNAs were subjected to lead
cleavage, DEPC modiﬁcation and partial digestion with
T1 RNase as illustrated in Supplementary Figures S1–S5.
The model of secondary structure of the 341nt of the WT
RNA derived from these experiments and from secondary
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Figure 2. Secondary structure models of WT and 2A, 4A and 2AU mutant 341nt RNAs. WT RNA: The ﬁrst 222nt (numbered from 30-end) of the
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4084 Nucleic Acids Research, 2010,Vol.38, No. 12structure predictions in silico is presented in Figure 2
(WT). This RNA fragment folded in seven stem–loops.
The 30 222nt were arranged in ﬁve stem–loops as in the
three previous published models (21–23). Upstream
sequences (nt 223–341) contained two short
single-stranded regions and two stem–loops. The ﬁrst
one (nt 229–317 from the 30-end) contained four bulges
and a 7-nt apical loop. This model is very similar to the
structure arrangement of the IIIcdef’ stem–loop proposed
by Smith et al. (22), with the exception of the apical part.
Indeed, The G280 and G289 and the A281 and the A290
were not reactive or only poorly to RNase T1, lead or
DEPC, suggesting that they could form G-A pairs or
interact with other RNA domains (in red in
Supplementary Figure S1 and S2B and D and
Supplementary Figure S4C and D). The same analysis
was done with 2A, 4A and 2AU mutant RNAs. A
close-up section of the structure spanning nucleotides
156–317 is boxed in rectangles in Figure 2. They
showed that residues 177–181 and 218–222 were sensitive
to lead cleavage or DEPC modiﬁcation in 2A and
4A RNAs compared to WT or 2AU compensatory
mutant RNA. The residues of other domains of the
mutants RNA displayed a similar reactivity to enzymatic
or chemical probing indicating that they were
not modiﬁed by mutations introduced in the SL-E1
domain (Supplementary Figure S1–S4 and Figure 2). To
further conﬁrm that the G to A mutation of residues 218
and 219 in 2A mutant induced also a mismatch of the
A220-U179 adjacent base pair, DMS treatment was per-
formed. As shown in Supplementary Figure S5A, the three
A residues (218–220) were sensitive to DMS treatment.
Altogether, these analyses indicate that in 2A and 4A
mutants, the SL-E1 helix is shortened due to mismatches
induced by mutations, whereas it is restored in the 2AU
mutant (Figure 2).
Change in the structure of the SL-E1 domain decreased
the initiation of RNA synthesis
Next, we tried to determine which RNA synthesis step was
aﬀected by 2A and 4A mutations. RNA synthesis by
NS5B polymerase can be divided into three major steps:
binding of the polymerase to the RNA template, initiation
and elongation of the RNA product.
We ﬁrst investigated the eﬀect of nucleotide changes
on NS5B binding. Gel-shift assays were performed and
the apparent kd value (kdapp) was determined for
WT and mutated RNAs. Similar values ranging from
519 and 579nM were obtained for WT RNA and
2A, 4A and 2AU RNAs, indicating that the lower
level of RNA synthesized from 2A and 4A RNA was
not due to a lower binding of NS5B to the template
(Supplementary Table S3). The same type of analysis
was performed with RNA harboring mutations in the
apical loop and the upper part of the stem. Comparable
aﬃnity for NS5B was found except for the 2GA mutant,
which displayed a 20% higher aﬃnity for the enzyme
(Supplementary Table S3).
We next analyzed the
32P-labeled RNA products
synthesized from WT and mutated RNA on a denaturing
polyacrylamide gel. To compare more accurately the
RNA synthesized from the diﬀerent templates, the same
amounts of labeled products were loaded in each lane
(50000c.p.m.). As shown in Supplementary Figure S6,
WT RNA allowed the synthesis of a major 341-nt-long
RNA product of the size of the template
(Supplementary Figure S6 compare lanes WT and M). A
band of higher molecular weight was also observed which
corresponds to two successive copies of the template (24).
The same migration pattern was observed when RNAs
mutated in the apical loop or at diﬀerent positions in
the SL-E1 helix were used as templates. No arrest bands
were observed during the synthesis, indicating that modi-
ﬁcation of the SL-E1 region did not induce premature
termination of the elongation product.
The RNA products obtained in the above experiments
were synthesized after several rounds of initiation and
elongation during a 2h incubation period. To analyze
the diﬀerent phases of the RNA synthesis in one round
of polymerization, we performed reaction kinetics in the
presence of heparin, a trapping agent allowing all
polymerase molecules not involved in initiation or elonga-
tion complexes to be captured. NS5B was pre-incubated
for 30min at 25 C with WT or mutated RNAs (2A, 4A
and 2AU) and the ﬁrst two nucleotides to be incorporated
(GTP and CTP) in order to allow the formation of stable
initiation complexes. Heparin and the two other
nucleotides (ATP and
32P-UTP) were then added and
incubation continued at the same temperature. Aliquots
of the reactions were removed at diﬀerent time points and
32P-labeled RNA products were analyzed quantitatively
and qualitatively. In these conditions, a plateau of
nucleotide incorporation was observed after 20min of
incubation with the 4 RNAs (Figure 3A). The kinetic
curve obtained with the 2AU mutant is indistinguishable
from that obtained with WT RNA both in the initial
linear phase and in the late phase. Conversely, when 2A
and 4A RNAs were used as templates, both the initial
velocity and the level of the plateau were reduced by
about 50% compared to WT and 2AU RNAs. As no
speciﬁc arrest bands were visible on the product analysis
on polyacrylamide gel (Figure 3B), this result suggests that
2A and 4A mutations impede the formation of initiation
complexes.
This prompted us to perform a gel-based initiation
assay to quantify the amount of ﬁrst di-nucleotide
product synthesized from WT and 2A, 4A and 2AU
mutant RNAs. The SL-E1 RNA harboring nucleotide
changes in the apical loop of SL-E1 (SLE1AL RNA)
was also included in this analysis. Values corresponding
to the mean of three independent experiments are given in
Figure 3C and a representative gel is presented in
Figure 3D. It appears that the amount of initiation
di-nucleotides synthesized from 2A and 4A RNAs was
reduced by 49% and 40%, respectively, compared to
WT RNA. Conversely, the quantity of di-nucleotides
synthesized from SLE1AL and 2AU RNA was equivalent
or slightly higher to that produced from WT RNA. Taken
together, these results indicate that the decrease in RNA
synthesis induced by structural modiﬁcations at the base
Nucleic Acids Research, 2010,Vol.38, No. 12 4085of the SL-E1 stem was due to an alteration of the initia-
tion step.
Mutation in SL-E1 stem–loop decreased RNA
synthesis in Huh7 cells
In HCV-infected cells, the NS5B polymerase functions in
association with a membranous complex composed of
other non-structural proteins (at least NS3, NS4A,
NS4B and NS5A) and cellular proteins. Interactions
between the NS5B and the template could be diﬀerent
when the viral polymerase is included in this complex.
To mimic these biological conditions more closely, we
used Huh7 cells that constitutively produced the HCV
replication complex from genotype 1b HCV (Huh7/
Rep5.1) and an RNA minigenome containing hygromycin
phosphotransferase and EGFP genes as reporter genes
(5UTR-H2AE-3UTR) (30).
As the translation of the reporter gene is under the
control of the HCV IRES present in the 50UTR, we ﬁrst
analyzed the impact of the above-mentioned mutations on
IRES-dependent translation. Indeed, nucleotide modiﬁca-
tions introduced into the SL-E1 domain of the 30-end of
the minus strand RNA induced changes in the IIIb
domain of the 50UTR that is involved in eIF3 binding
(37). This domain folds in a hairpin structure with an
internal and an apical loop of 5 and 14nt, respectively
(3). Introduction of 2A or 4A mutations induced 2 or 4
GC to GU base pair changes respectively in the lower part
of the IIIb helix, whereas the 2AU mutation leads to 2 GC
to AU base pair changes (Figure 4A). The 2GA, 3AU, GC
and SLE1AL induced nucleotide modiﬁcations of the
apical loop of the IIIb region (Figure 4A). We assessed
the eﬀect of these nucleotide changes on IRES eﬃciency
by inserting WT and mutated HCV sequences (nt 1–370)
into the pIRF vector, so that HCV IRES drove initiation
of RLuc translation (Figure 4B). Bicistronic capped RNA
transcripts were transfected into Huh7-QR cells and
luciferase activity was determined after 24h. The mean
RLuc/FLuc ratio for three independent experiments was
expressed as a percentage of the ratio obtained for Huh7
transfected with bicistronic RNA containing the WT
IRES sequence (Figure 4C). Sequence changes in the
IIIb apical loop (3AU, GC, 2GA and SLE1AL mutants)
did not alter the translation eﬃciency, or did so only by
about 20%. With 2A and 2AU mutants bearing
nucleotide changes in the IIIb helix, IRES-dependent
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Figure 3. Some mutations in the SL-E1 stem–loop decreased initiation of RNA synthesis. For the single-round replication assay, HCV RdRp and
RNA were pre-incubated for 30min at 25 C in the reaction mixture without ATP and UTP. Heparin (MW 4000–6000Da, 200mg/ml) was then added
followed by ATP and [
32P]UTP. The reaction mixture was further incubated at 25 C for 0, 5, 10, 20 and 60min. The
32P RNA products were (A):
quantiﬁed after TCA precipitation and counted in a Wallac counter (ﬁlled circles, WT RNA; open circles, 2AU RNA; ﬁlled triangles, 2A RNA;
empty triangles, 4A RNA) or (B): analyzed on denaturing polyacrylamide gels. For the gel-base initiation assay, an RdRp assay was performed with
0.5mM GTP and 10mM CTP with 4mCi [a-
32P] CTP (3000Ci mmol
–1) as only added NTP. The reaction was run at 25 C for 10, 30 and 60min.
Initiation products were run in a 20% acrylamide gel in TBE buﬀer, submitted to electronic autoradiography using a Pharos apparatus (Biorad) and
quantiﬁed using the Quantity one software (Biorad). (C) Quantiﬁcation of initiation products synthesized with WT and mutant RNAs after 1h
incubation. Data correspond to the mean of three independent experiments±SD. (D) Analysis of initiation products on polyacrylamide gel
electrophoresis. M: pppGpC molecular weight marker.
4086 Nucleic Acids Research, 2010,Vol.38, No. 12translation was reduced by 52% and 18%, respectively.
The nucleotide modiﬁcations corresponding to 4A
mutant completely abolished IRES-dependent translation.
Consequently, the eﬀect of this latter mutation on RNA
synthesis driven by HCV RC in Huh7 cells could not be
assessed.
To analyze the impact of the six other mutations on
RNA replication in a cellular context, we ﬁrst modiﬁed
the 50UTR and the 30UTR sequences of the 5UTR-H2AE-
3UTR minigenomes (Figure 5A). As the basal construct
contained UTR sequences from the HCV Con1, we
replaced both sequences by those of the H77 HCV used
in the previous in vitro RNA synthesis. This modiﬁcation
did not modify the replication of the minigenome in
Huh7/Rep5.1 cells (data not shown). 5UTR-H2AE-
3UTR minigenomes (positive strand) containing WT or
mutated 50UTR were transfected into Huh7/Rep5.1 or in
Huh7-QR cells as a control. Huh7/Rep5.1 cells were also
transfected with a minigenome containing only the EGFP
gene as an additional negative control (5UTR-EGFP-
3UTR). Sixteen hours after transfection, the percentage
of EGFP-positive cells was determined by ﬂow cytometry
to normalize the transfection eﬃciency. The rest of
the cells were maintained in culture in the presence of
50mg/ml hygromycin and 500mg/ml G418. After
3 weeks, the number of resistant colonies was determined.
As expected, cell colonies were never observed
in hygromycin-cultured Huh7-QR cells transfected by
WT 5UTRH77-H2AE-3UTRH77 minigenome or with
hygromycin-G418-cultured Huh7/Rep5.1 transfected
with the 5UTR-EGFP-3UTR minigenome (Figure 5B).
Conversely, with the 5UTRH77-H2AE-3UTRH77
minigenome containing WT H77-50UTR, 400–1500 resis-
tant colonies per microgram of transfected RNA were
obtained. A change of 1–3nt in the apical loop of SL-E1
(3AU, GC and 2GA mutants) did not reduce the number
of hygromycin-resistant colonies compared to the WT
construct (Figure 5C). Even a 54% and 30% increase
was observed with 3AU and 2GA minigenomes, respec-
tively (Figure 5C). Modiﬁcation of the 6nt in the upper
part of SL-E1 (sequence homologous to SLII of 30UTR)
reduced to 61% the number of resistant colonies
(SLE1AL mutant). When Huh7/Rep5.1 cells were
transfected with minigenomes harboring nucleotide
changes that disrupt the lower helix structure of SL-E1
(2A mutant, Figure 5C), the number of hygromycin-
resistant colonies was reduced to 12%. Compensatory
nucleotide exchange (2AU mutant) allowed the growth
of cell colonies to 80% of the wild-type level.
Finally, to assess whether the reduced number of cell
colonies observed with 2A and SLE1AL minigenomes
could not be attributed to a lower stability of mutated
RNA minigenomes, total cellular RNAs were extracted
4h after transfection and analyzed by northern blot with
an EGFP probe. As illustrated in Figure 5D, similar
amounts of 2A and SLE1AL minigenome were recovered
compared to wild-type or 2GA minigenomes, ruling out
the hypothesis of a lower stability of 2A and SLE1AL
RNAs. Taken together, these results strongly suggest
that the structure of the SL-E1 domain is important for
A
3AU, GC, 
2GA, SLE1AL
2A U
U 4A U
2AU A
CAP
HCV
5’UTR 
Renilla
luciferase
Firefly
luciferase
HCV
3’UTR
B
R
/
F
 
(
%
 
W
T
)
0
20
40
60
80
100
120
1a WT 2A 4A 2AU 3AU GC 2GA SL-
E1AL
C
RNA
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Nucleic Acids Research, 2010,Vol.38, No. 12 4087eﬃcient RNA synthesis from the 30 sequence of the
HCV minus strand RNA by NS5B, either alone or in
the RC.
DISCUSSION
During the past few years, important information on the
cis-acting elements required for replication of plus-strand
RNA virus has been obtained. In the case of HCV, such
elements have been mapped not only in 50 and 30 UTR
but also in the capsid and NS5B coding sequence
(18,19,38,39). Cis-acting elements located in the 30UTR
and in the NS5B-coding sequences are likely involved in
the initiation of minus RNA synthesis from the 30-end of
the plus RNA, whereas those found in the 50UTR and in
the capsid-coding sequence are presumably involved in
initiation of plus RNA synthesis from the 30-end of
minus strand RNA. The exact role of these RNA
sequences in the diﬀerent steps of viral RNA synthesis is
poorly understood, although one RNA element (SL-V or
5BSL3.2) speciﬁcally binds the NS5B polymerase in vitro
(38). In the 30UTR, both the conserved 30X sequence and
the polyU-C stretch are necessary for viral replication in
chimpanzee and multiplication of RNA replicon in Huh7
cells (10–12). The involvement of these sequences in RNA
synthesis is unknown especially because the 30UTR is
poorly replicated by the NS5B polymerase in vitro and
because initiation frequently occurred at internal sites
(17,24,40). Conversely, the 30-end of minus strand RNA
is eﬃciently replicated in vitro by HCV polymerase that
initiated on the 30 ﬁrst nucleotide of the template (24,41).
Data obtained with recombinant polymerase or in the
replicon system suggested that sequences and/or structures
in the 104 or 125nt at 30-end allow a low level of replica-
tion, but that upstream sequences are necessary for
eﬃcient RNA synthesis (24–26).
To identify other RNA elements involved in RNA syn-
thesis from this RNA domain, we analyzed the role of the
SL-E1 stem–loop in RNA synthesis both in vitro and
in cellulo. We chose this region for two reasons. First,
antisense hybridization to this domain strongly inhibits
in vitro RNA synthesis (36). Second, the upper part of
this structure displays a common feature with the SL-II
stem–loop of the 30UTR with an identical 6-nt sequence
(21,22). Our data indicated that nucleotide changes that
destabilized the lower part of the SL-E1 stem reduced
RNA synthesis catalyzed by recombinant NS5B by a
factor 2, whereas the level of RNA synthesis remained
constant or increased slightly when mutations were
introduced into the sequence homologous to SL-II. The
change in the SL-E1 hairpin structure did not decrease
NS5B binding or induce any modiﬁcation of the initiation
site or polymerase dissociation during elongation.
Surprisingly, it reduced the formation of the functional
initiation complex, even though this RNA region is
distant from the 30end of the template (nt 177–222).
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4088 Nucleic Acids Research, 2010,Vol.38, No. 12The data reported here does not allow us to determine the
role of this domain in initiation. Gel-shift experiments
showed no diﬀerences in enzyme aﬃnity between WT
RNA or 2A and 4A mutant RNA that would have
caused ineﬃcient initiation. However, it cannot be
excluded that subtle interactions occurred between NS5B
and the SL-E1 stem–loop after the correct positioning
of the ﬁrst 2nt, before the formation of the ﬁrst
phospho-diester bond. Modiﬁcations of the SL-E1
domain could also induce changes in the tertiary structure
of the 341-nt fragment, which may alter the ratio of pro-
ductive and unproductive initiation complex. In this
regard, it should be noted that introduction of a C224U
nucleotide change, which is speciﬁcally found in RNA
from genotype 3 HCV, into a genotype 1 sequence also
induced a 2-fold reduction of RNA synthesis from the
30-end of minus strand model RNAs (42). In silico second-
ary structure predictions indicated that this modiﬁcation
led to a 3-base lengthening of the SL-E1 stem without
aﬀecting the secondary structure of other RNA
domains. Further experiments using surface plasmon
resonance UV-monitored spectroscopy could help to
determine more precisely the interaction between NS5B
and the WT or mutant RNAs in the presence or in the
absence of NTP.
Before testing the eﬀect of SL-E1 mutations on
RNA synthesis in a cellular context, we evaluated their
impact on translation from the 50UTR using a bicistronic
reporter construct. Indeed, during RNA replication,
the nucleotide changes introduced into the SL-E1 stem–
loop of the 30-end of minus strand RNA induced
nucleotide changes in the IIIb domain of the HCV
IRES. The latter has been shown to contain a critical
determinant of eIF3 binding (37). Inversion of the apical
loop sequence or replacement of the HCV loop by the
BVDV loop reduced the IRES translation eﬃciency by
2-fold (37,43). We found that the IIIb loop modiﬁcation
corresponding to nucleotide changes of the sequence
homologous to the SLII loop of the 30UTR did not
modify or only slightly modiﬁed the translation level
(Figure 4: 3AU, GC, 2GA and SLE1AL mutants). The
replacement of two or four GC base pairs by two or four
GU base pairs in the IIIb stem (2A or 4A mutants) led to
about a 2-fold or total reduction of translation, respec-
tively. Conversely, replacing the two GU base pairs cor-
responding to the 2A mutant with two AU base pairs
(2AU mutant) restored the translation level to 82% of
WT translation (Figure 4C).
We then evaluated the eﬀect of mutations in the SL-E1
stem–loop on viral RNA synthesis in a cellular context
mimicking viral RNA replication in HCV-infected cells.
To this end, we used a minigenome system developed in
our laboratory (30) because in this cellular model the syn-
thesis of the HCV nonstructural proteins is independent of
translation and replication of the minigenome driven by
HCV UTR sequences. Consequently, a lower minigenome
replication could not be attributed to a decrease in the RC
amount in Huh7 cells. This allowed us to demonstrate that
the intact structure of the SL-E1 stem–loop contributes to
eﬃcient RNA synthesis from the 30-end of HCV minus
strand RNA by the viral replication complex. Indeed,
mutations that destabilize the lower part of the stem led
to an 8-fold reduction of hygromycin-resistant cell clones
(Figure 5C, 2A mutant), whereas compensatory mutations
restored the number of resistant clones to almost the WT
level (Figure 5C, 2AU mutant). It could be argued that
the lower amount of resistant colonies obtained with
2A minigenome resulted from a lower hygromycin-
phosphotransferase production due to its lower IRES
activity (48%, Figure 4) rather than from a decrease in
RNA synthesis. This hypothesis is unlikely, however, since
previous data indicated that WT IRES activity allowed
the production of a suﬃcient amount of hygromycin-
phosphotransferase to confer resistance to 300mg/ml
hygromycin (30). As all the results reported here were
obtained after selection in 50mg/ml hygromycin, the trans-
lation decrease induced by 2A mutations should not aﬀect
the minigenome capacity to confer cell resistance to the
antibiotic.
The role of the sequence shared by SL-E1 and SLII of
30UTR in viral RNA synthesis is less clear. Modiﬁcation
of 1–3nt in this sequence did not signiﬁcantly hamper
minigenome replication (GC minigenome) or even
induce a slight increase (3AU and 2GA minigenomes).
It should be noted that the two latter mutations also
induced a small increase in in vitro RNA synthesis.
These results are in agreement with those previously
reported by Grassmann et al. (43) who showed a
moderate eﬀect of mutations in the apical loop of the
IIIb domain using diﬀerent nucleotide changes and a
replicon system. However, when all 6nt of the sequence
homologous to SLII of the 30UTR were changed
simultaneously (SLE1AL mutant), the replication level
of the minigenome decreased by 39% compared to WT.
The eﬀect of the SLE1AL mutation was diﬀerent when
RNA synthesis was performed in Huh7 cells by the
HCV replication complex or in vitro by the puriﬁed
NS5B. In the latter case, SLE1AL mutations had no
eﬀect (Figure 1B). Interactions of this sequence with
other viral or cellular components of the replication
complex in Huh7 cells could explain this diﬀerence.
During the preparation of this manuscript, Friebe and
Bartenschlager (44) published a paper reporting the
eﬀect of large deletion in diﬀerent domains of the HCV
50-end on the replication of chimeric replicons in Huh7
cells. In agreement with the data reported here, they
showed that the SL-E1 domain is an auxiliary element
for replication. Our site-directed mutagenesis study con-
ﬁrmed that the reduced replication is due to structure
modiﬁcations rather than changes in the primary
sequence of the RNA. In addition, we demonstrate that,
at least in vitro, this alteration aﬀects the initiation step of
the viral RNA synthesis. This result makes this RNA
domain an attractive target for the development of
antiviral molecules directed against RNA elements such
as antisense oligonucleotides, aptamers or siRNAs. The
fact that antisense oligonucleotides against a part of
this RNA domain completely inhibited in vitro RNA syn-
thesis catalyzed by HCV NS5B (36) suggests that drugs
targeting this RNA domain could be included in
anti-HCV treatments.
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